Barchart on Facebook
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Cancer Genetics Inc (CGIX)

Cancer Genetics Inc (CGIX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 5,261
  • Shares Outstanding, K 2,308
  • Annual Sales, $ 7,310 K
  • Annual Income, $ -6,710 K
  • 60-Month Beta 2.55
  • Price/Sales 1.07
  • Price/Cash Flow 30.77
  • Price/Book 1.51
Trade CGIX with:

Price Performance

See More
Period Period Low Period High Performance
1-Month
2.11 +8.06%
on 10/29/20
4.90 -53.47%
on 10/12/20
-1.94 (-45.97%)
since 09/29/20
3-Month
2.11 +8.06%
on 10/29/20
10.39 -78.06%
on 08/24/20
-0.68 (-22.97%)
since 07/29/20
52-Week
1.92 +18.75%
on 03/19/20
10.39 -78.06%
on 08/24/20
-0.93 (-28.97%)
since 10/29/19

Most Recent Stories

More News
Cancer Genetics, Inc. Increases Previously Announced Bought Deal to $3.0 Million

Cancer Genetics, Inc. (Nasdaq: CGIX) ("Cancer Genetics"), a leader in drug discovery and preclinical oncology and immuno-oncology services, announced today that, due to demand, the underwriter has agreed...

CGIX : 2.28 (-32.94%)
Cancer Genetics, Inc. Announces $2.0 Million Bought Deal Offering

Cancer Genetics, Inc. (Nasdaq: CGIX) ("Cancer Genetics"), a leader in in drug discovery and preclinical oncology and immuno-oncology services, announced today that it has entered into an underwriting agreement...

CGIX : 2.28 (-32.94%)
SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Reminds Investors of Investigations of EIDX, ARA, MVC, and CGIX Mergers

Rigrodsky & Long, P.A. announces that it is investigating:

CGIX : 2.28 (-32.94%)
EIDX : 72.13 (+0.11%)
ARA : 11.41 (-0.61%)
MVC : 7.46 (-0.27%)
SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Reminds Investors of Investigations of EIDX, VRTU, CBMG, and CGIX Mergers

Rigrodsky & Long, P.A. announces that it is investigating:

CGIX : 2.28 (-32.94%)
CBMG : 18.28 (+0.33%)
EIDX : 72.13 (+0.11%)
VRTU : 50.10 (-0.04%)
SHAREHOLDER ALERT: Halper Sadeh LLP Continues to Investigate the Following Mergers; Shareholders are Encouraged to Contact the Firm - DCOM, ARA, CGIX, BLDR

, /PRNewswire/ -- Halper Sadeh LLP, a global investor rights law firm, is investigating:

DCOM : 12.69 (+5.05%)
ARA : 11.41 (-0.61%)
CGIX : 2.28 (-32.94%)
BLDR : 30.01 (-1.64%)
Lifshitz Law Firm, P.C. Announces Investigation of American Renal Associates Holdings, Inc. (NYSE: ARA), BMC Stock Holdings, Inc., Builders FirstSource, Inc., Cancer Genetics, Inc., Cellular Biomedicine Group, Inc., Eidos Therapeutics, Inc., Montage Resources Corporation, MyoKardia, Inc. and Yintech Investment Holdings Limited

, /PRNewswire/ --

ARA : 11.41 (-0.61%)
BMCH : 39.04 (-2.01%)
BLDR : 30.01 (-1.64%)
CGIX : 2.28 (-32.94%)
CBMG : 18.28 (+0.33%)
MR : 5.15 (-2.28%)
MYOK : 223.32 (+0.23%)
YIN : 7.28 (+1.11%)
Lifshitz Law Firm, P.C. Announces Investigation of BMC Stock Holdings, Inc. (NASDAQ:BMCH), Cancer Genetics, Inc. (NASDAQ: CGIX), Cellular Biomedicine Group, Inc. (NASDAQ: CBMG), and Varian Medical Systems, Inc. (NYSE: VAR)

BMC Stock Holdings, Inc. (NASDAQ:BMCH) - Builders FirstSource, Inc. (NASDAQ:BLDR)

MDSY : 0.73 (+4.29%)
BLDR : 30.01 (-1.64%)
CGIX : 2.28 (-32.94%)
CBMG : 18.28 (+0.33%)
VAR : 172.28 (-0.08%)
BMCH : 39.04 (-2.01%)
Large Study shows 230 Times Higher One Year Cancer Risk If Tumor Cell Clusters are Detected in Blood of Normal Individuals - Datar Cancer Genetics

MUMBAI, India and LONDON, Sept. 29, 2020 /PRNewswire/ -- A landmark study published in the American Association of Cancer Research's (AACR) prestigious journal 'Cancer Prevention Research' has shown that...

CGIX : 2.28 (-32.94%)
Large Study shows 230 Times Higher One Year Cancer Risk If Tumor Cell Clusters are Detected in Blood of Normal Individuals - Datar Cancer Genetics

and , /PRNewswire/ -- A landmark study published in the American Association of Cancer Research's (AACR) prestigious journal 'Cancer Prevention Research' has shown that it is possible to identify healthy...

CGIX : 2.28 (-32.94%)
IMPORTANT SHAREHOLDER ALERT: Halper Sadeh LLP Reminds Shareholders About Its Ongoing Investigations; Investors are Encouraged to Contact the Firm - CGIX, YIN, OTEL, BMCH

, /PRNewswire/ --

CGIX : 2.28 (-32.94%)
YIN : 7.28 (+1.11%)
OTEL : 11.51 (+0.17%)
BMCH : 39.04 (-2.01%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 8% Sell with a Weakening short term outlook on maintaining the current direction.

The market is in highly oversold territory. Beware of a trend reversal.

See More Share

Business Summary

Cancer Genetics, Inc. operates as a diagnostics company focused on developing and commercializing proprietary genomic tests and services to improve the diagnosis, prognosis and response to treatment of cancer. The company's tests target cancers, including hematological, urogenital, and HPV-associated...

See More

Key Turning Points

2nd Resistance Point 2.49
1st Resistance Point 2.38
Last Price 2.28
1st Support Level 2.14
2nd Support Level 2.01

See More

52-Week High 10.39
Fibonacci 61.8% 7.15
Fibonacci 50% 6.16
Fibonacci 38.2% 5.16
Last Price 2.28
52-Week Low 1.92

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar